Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

GLPG0634 100mg capsule once a day for 10 days

Trial Locations (1)

2060

SGS LSS Clinical Pharmacology Unit Antwerp, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galapagos NV

INDUSTRY